Abstract
Donation after circulatory death (DCD) arguably has the greatest potential to provide transplantable organs. The vast majority of people die of causes that do not lead to brain death (98 %) [1] and thus DCD could meet the needs of organ transplantation based upon the actual numbers of potential donors alone. DCD liver transplantation has also played a unique role in the genesis of solid organ transplantation and paved the way for early pioneers of the speciality.
There are many challenges, however, to start successful DCD programs. In contemporary practice, despite large numbers of potential donors, DCD is not the ideal solution to the shortage of organs for transplantation due to complications relating primarily to ischaemia-reperfusion injury which are responsible for primary non-function (PNF) and/or delayed graft function. The liver is particularly sensitive to ischaemia-reperfusion injury and displays organ-specific damage in terms of biliary ischaemia. Ethical issues, societal idiosyncrasies and religious beliefs vary between nations and have a vast impact upon organ donation. Some of the more important issues that affect DCD follow. Controlled DCD was not possible in some countries, such as Spain, where withdrawal of life-sustaining treatment was not an accepted practice. However, this is changing and a pilot controlled DCD is on its way; as all religious scriptures were created before organ donation no religion states organ donation should be prohibited though some individuals perceive this to be so [2]; there is a perception by some people that efforts at resuscitation, provided by healthcare professionals, would be negatively influenced if uncontrolled DCD was a possible outcome for the patient in cardiac arrest [3]; certain noninvasive and invasive procedures are required during uncontrolled DCD before consent for donation can be sought. Finally, there are difficult logistic issues surrounding liver procurement, particularly for uncontrolled DCD. Thus the process of DCD is presented with strong challenges from society, individuals and the technical and logistical process of liver procurement itself.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Centers for Disease Control and Prevention. Vital Stat Rep. 2002;50
Randhawa G. Death and organ donation: meeting the needs of multiethnic and multifaith populations. Br J Anaesth. 2012;108 Suppl 1:i88–91.
Volk ML, Warren GJ, Anspach RR, Couper MP, Merion RM, Ubel PA. Attitudes of the American public toward organ donation after uncontrolled (sudden) cardiac death. Am J Transplant. 2010;10:675–80.
Kootstra G, Kievit J, Nederstigt A. Organ donors: heartbeating and non-heartbeating. World J Surg. 2002;26:181–4.
Starzl TE, Marchioro TL, Huntley RT, Rifkind D, Rowlands DT, Dickinson Jr TC. Experimental and clinical homotransplantation of the liver. Ann N Y Acad Sci. 1964;120:739–65.
Calne RY, Williams R. Liver transplantation in man. I. Observations on technique and organization in five cases. Br Med J. 1968;4:535–40.
A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA. 1968;205:337–40.
Diagnosis of brain death. Statement issued by the honorary secretary of the Conference of Medical Royal Colleges and their Faculties in the United Kingdom on 11 October 1976. Br Med J. 1976;2:1187–88.
Diagnosis of Brain Death. Lancet. 1976;2:1069–70.
Weber M, Dindo D, Demartines N, Ambuhl PM, Clavien PA. Kidney transplantation from donors without a heartbeat. N Engl J Med. 2002;347:248–55.
Akoh JA, Denton MD, Bradshaw SB, Rana TA, Walker MB. Early results of a controlled non-heart-beating kidney donor programme. Nephrol Dial Transplant. 2009;24:1992–6.
Summers DM, Johnson RJ, Allen J, Fuggle SV, Collett D, Watson CJ, et al. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. Lancet. 2010;376:1303–11.
Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg. 2005;242:724–31.
Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Bronsther O, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation. 1995;59:197–203.
D'Alessandro AM, Hoffmann RM, Knechtle SJ, Odorico JS, Becker YT, Musat A, et al. Liver transplantation from controlled non-heart-beating donors. Surgery. 2000;128:579–88.
Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004;239:87–92.
Muiesan P, Girlanda R, Jassem W, Melendez HV, O'Grady J, Bowles M, et al. Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts. Ann Surg. 2005;242:732–8.
Reich DJ, Munoz SJ, Rothstein KD, Nathan HM, Edwards JM, Hasz RD, et al. Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation. 2000;70:1159–66.
Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation. 2003;75:1659–63.
Kaczmarek B, Manas MD, Jaques BC, Talbot D. Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience. Transplant Proc. 2007;39:2793–5.
Monbaliu D, Van GF, Troisi R, De HB, Lerut J, Reding R, et al. Liver transplantation using non-heart-beating donors: Belgian experience. Transplant Proc. 2007;39:1481–4.
Coggon J, Brazier M, Murphy P, Price D, Quigley M. Best interests and potential organ donors. BMJ. 2008;336:1346–7.
Richards B, Rogers WA. Organ donation after cardiac death: legal and ethical justifications for antemortem interventions. Med J Aust. 2007;187:168–70.
Bell MD. Non-heart beating organ donation: old procurement strategy–new ethical problems. J Med Ethics. 2003;29:176–81.
Bell MD. Non-heart beating organ donation: in urgent need of intensive care. Br J Anaesth. 2008;100:738–41.
Gardiner D, Riley B. Non-heart-beating organ donation – solution or a step too far? Anaesthesia. 2007;62:431–3.
Mandell MS, Zamudio S, Seem D, McGaw LJ, Wood G, Liehr P, et al. National evaluation of healthcare provider attitudes toward organ donation after cardiac death. Crit Care Med. 2006;34:2952–8.
Department of Health. Organ donation after circulatory death. Report of a consensus meeting. Intensive Care Society, NHS Blood and Transplant, and British Transplantation Society, 2010. Available from http://www.ics.ac.uk/intensive_care_professional/standards_and_guidelines/dcd.
Dominguez-Gil B, Haase-Kromwijk B, Van LH, Neuberger J, Coene L, Morel P, et al. Current situation of donation after circulatory death in European countries. Transpl Int. 2011;24:676–86.
Bernat JL, D'Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, et al. Report of a national conference on donation after cardiac death. Am J Transplant. 2006;6:281–91.
Stewart ZA, Cameron AM, Singer AL, Montgomery RA, Segev DL. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant. 2009;9:286–93.
Fondevila C, Hessheimer AJ, Ruiz A, Calatayud D, Ferrer J, Charco R, et al. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant. 2007;7:1849–55.
Jimenez-Galanes S, Meneu-Diaz MJ, Elola-Olaso AM, Perez-Saborido B, Yiliam FS, Calvo AG, et al. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation. Liver Transpl. 2009;15:1110–8.
Otero A, Gomez-Gutierrez M, Suarez F, Arnal F, Fernandez-Garcia A, Aguirrezabalaga J, et al. Liver transplantation from Maastricht category 2 non-heart-beating donors. Transplantation. 2003;76:1068–73.
Quintela J, Gala B, Baamonde I, Fernandez C, Aguirrezabalaga J, Otero A, et al. Long-term results for liver transplantation from non-heart-beating donors maintained with chest and abdominal compression-decompression. Transplant Proc. 2005;37:3857–8.
Fondevila C, Hessheimer AJ, Flores E, Ruiz A, Mestres N, Calatayud D, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant. 2012;12:162–70.
Huddle TS, Schwartz MA, Bailey FA, Bos MA. Death, organ transplantation and medical practice. Philos Ethics Humanit Med. 2008;3:5.
Kaufman BJ, Wall SP, Gilbert AJ, Dubler NN, Goldfrank LR. Success of organ donation after out-of-hospital cardiac death and the barriers to its acceptance. Crit Care. 2009;13:189.
Fondevila C, Hessheimer AJ, Maathuis MH, Munoz J, Taura P, Calatayud D, et al. Superior preservation of DCD livers with continuous normothermic perfusion. Ann Surg. 2011;254:1000–7.
Gong J, Lao XJ, Wang XM, Long G, Jiang T, Chen S. Preservation of non-heart-beating donor livers in extracorporeal liver perfusion and histidine-trytophan-ketoglutarate solution. World J Gastroenterol. 2008;14:2338–42.
Butler AJ, Rees MA, Wight DG, Casey ND, Alexander G, White DJ, et al. Successful extracorporeal porcine liver perfusion for 72 hr. Transplantation. 2002;73:1212–8.
Imber CJ, St Peter SD, Lopez dC, I, Pigott D, James T, Taylor R et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation. 2002;73:701.
Guarrera JV, Henry SD, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein MJ, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010;10:372–81.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Muiesan, P., Tinti, F., Mitterhofer, A.P. (2014). How to Initiate DCD Program for Liver Transplantation. In: Asano, T., Fukushima, N., Kenmochi, T., Matsuno, N. (eds) Marginal Donors. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54484-5_9
Download citation
DOI: https://doi.org/10.1007/978-4-431-54484-5_9
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54483-8
Online ISBN: 978-4-431-54484-5
eBook Packages: MedicineMedicine (R0)